Praxis Precision Medicines, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| PRAX | AXSM | ACAD | XENE | PTCT | RAPP | |
|---|---|---|---|---|---|---|
| Market cap | 7.02B | 8.70B | 3.34B | 3.47B | 5.25B | 1.45B |
| P/E (TTM) | — | — | 8.6 | — | — | — |
| Forward P/E | -26.9 | 35.6 | 21.5 | -7.6 | 26.5 | -5.9 |
| Price/book | 5.2 | 104.2 | 2.6 | 2.8 | -31.7 | 3.4 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +378.64% | +34.39% | −4.67% | −11.73% | −4.80% | +21.18% |
| Today | −3.26% | −1.40% | −1.87% | −1.73% | −2.75% | −1.63% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All PRAX news ›BTIG maintains Buy rating on Praxis Precision Medicine, $826 price target
TradingView BTIG maintains Buy rating on Praxis Precision Medicine, $826 price target BTIG maintained their Buy rating on Praxis Precision Medicine's stock with a price target of $826.00. The price target implies an upside of 191.3% from…
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
The Manila Times The restricted stock units will vest in four equal annual installments, subject to the employee’s continued employment with Praxis on each vesting date. Praxis Precision Medicines is a fully integrated, leading CNS…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
manilatimes.net2
-
tradingview.com1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.